ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,887.99
      0.13%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Proven Vct Plc (PVN) Quote

      Proven Vct Plc

      Proven Vct Plc (PVN)

      Piovan Spa
      61.00
      0.00
      (0.00%)
      Closed July 28 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      61.00
      Bid
      59.50
      Ask
      62.50
      Volume
      0.00
      61.00 Day's Range 61.00
      58.50 52 Week Range 61.00
      Market Cap
      166.112M
      Previous Close
      61.00
      Open
      61.00
      Last Trade
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      262,881
      Shares Outstanding
      272,315,320
      Dividend Yield
      5.33%
      PE Ratio
      -12.01
      Earnings Per Share (EPS)
      -0.05
      Revenue
      -9.88M
      Net Profit
      -13.83M

      About Proven Vct Plc

      Sector
      Investors, Nec
      Industry
      Investors, Nec
      Website
      www.provenvcts.co.uk
      Headquarters
      London, Gbr
      Founded
      1970
      Proven Vct Plc is listed in the Investors sector of the London Stock Exchange with ticker PVN. The last closing price for Proven Vct was 61p. Over the last year, Proven Vct shares have traded in a share price range of 58.50p to 61.00p.

      Proven Vct currently has 272,315,320 shares outstanding. The market capitalization of Proven Vct is £166.11 million. Proven Vct has a price to earnings ratio (PE ratio) of -12.01.

      PVN Latest News

      More News

      ProVen VCT plc: Directorate change

      ProVen VCT plc: Directorate change ProVen VCT plcDirectorate changes 23 July 2024 ProVen VCT plc ("PVN" or the "Company") announces that James Barbour-Smith has been appointed as a Non-Executive...

      July 23 2024
      UK Regulatory

      TRADING UPDATES: Critical Mineral Resources strikes Igli deal

      The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by ...

      July 17 2024
      Alliance News

      ProVen VCT plc: Result of AGM

      ProVen VCT plc: Result of AGM ProVen VCT plc 17 July 2024 Annual General Meeting At the Annual General Meeting (“AGM”) of ProVen VCT plc, held on Wednesday 17 July 2024, all resolutions were...

      July 17 2024
      UK Regulatory

      ProVen VCT plc: Interim Management Statement

      ProVen VCT plc: Interim Management Statement ProVen VCT plcInterim Management Statement for the three months ended 31 May 2024 ProVen VCT plc (the “Company”) presents an Interim Management...

      July 17 2024
      UK Regulatory

      ProVen VCT plc: Issue of Equity

      ProVen VCT plc: Issue of Equity ProVen VCT plc Issue of equity3 July 2024 The Directors of ProVen VCT plc announce an allotment on 3 July 2024 of ordinary shares of 10p each ("Ordinary Shares...

      July 03 2024
      UK Regulatory

      ProVen VCT plc: Total voting rights

      ProVen VCT plc: Total voting rights ProVen VCT plcTotal Voting Rights3 July 2024 In conformity with the Disclosure and Transparency Rule 5.6.1, ProVen VCT plc announces that the Company's capital...

      July 03 2024
      UK Regulatory

      ProVen VCT plc: Transaction in Own Shares

      ProVen VCT plc: Transaction in Own Shares ProVen VCT plc Transaction in own shares20 June 2024 ProVen VCT plc announces that, on 20 June 2024, it purchased the following shares for cancellation:...

      June 20 2024
      UK Regulatory

      ProVen VCT plc: Annual Financial Report

      ProVen VCT plc: Annual Financial Report ProVen VCT plc Annual Financial ReportYear ended 29 February 2024 ProVen VCT plc, managed by Beringea LLP, today announces the final results for the year...

      June 11 2024
      UK Regulatory

      Extension of 2024/2025 Offer

      Extension of 2024/2025 Offer ProVen VCT plcProVen Growth and Income VCT plc 10 June 2024 Extension of 2024/2025 Offer On 16 January 2024, ProVen VCT plc and ProVen Growth and Income VCT plc (the...

      June 10 2024
      UK Regulatory

      ProVen VCT plc: Total voting rights

      ProVen VCT plc: Total voting rights ProVen VCT plcTotal Voting Rights1 May 2024 In conformity with the Disclosure and Transparency Rule 5.6.1, ProVen VCT plc announces that the Company's capital...

      May 01 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      100616161702261DE
      400616159.5821160.90716339DE
      1200616159.526288160.99818763DE
      261.52.5210084033659.56159.522014460.60094361DE
      521.52.5210084033659.56158.512255360.19577177DE
      156-9.5-13.47517730570.57458.55724163.48177272DE
      260-14-18.6666666667757558.54089766.25181422DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      Discussion

      View Full Feed
      learningcurve2020 learningcurve2020 5 minutes ago
      A lot of insults there. LOL. You yourself just told us the knowledge transfer from Cognate to Advent was critical. You can't even keep your own story straight!

      >>But the knowledge and expertise is not at the CDMO,
      CDMO
      StayHumble StayHumble 5 minutes ago
      $PM annotatedNewly Mintedmockup figuresof Hammel in self-serving way to show features that are not shown or discussed in Hammel itself."


      $PM recognized Hammel’s disclosure was lacking
      https://media.tenor.com/Um5wy5kuZiUAAAAC/anchorman-science.gif
      HCMC
      StayHumble StayHumble 5 minutes ago
      GreenAcres acquisition will propel annual top-line revenue to$70million+


      https://www.healthiercmc.com/news/2024/7/24/hcmc-announces-the-acquisition-of-greenacres-market-with-5-stores-located-in-kansas-and-oklahoma
      HCMC
      PhantomCitadel74 PhantomCitadel74 6 minutes ago
      No way are you still here 😂😂😂😂😂😂😂😂 You get paid on Sundays little man?
      NWBO
      WooptdooU WooptdooU 8 minutes ago
      I am not talking. Posting does not replace interaction.
      Funny, how so many are trying to help Newbies, yet they ignore the dreaded relevance.
      Newbies don't have me on ignore. At least not at the start. :-)
      LWLG
      StayHumble StayHumble 10 minutes ago
      https://mdmwoundventures.com ✅DoublePrintsHuzzah
      UBQU
      TRAPPER JIM TRAPPER JIM 11 minutes ago
      Thanks. You know how much we love our softball games. LOLOL
      exwannabe exwannabe 11 minutes ago
      NWBO did that. NWBO did submit its trial design before initiating the externally controlled trial. NWBO submitted an IND with a trial design SPA and SAP.
      The trial was started in 2007. The IND did not include an ECA. The SAP with the ECA was created in 2020. The FDA states clearly the ECA co
      NWBO
      02opida 02opida 14 minutes ago
      EESH
      EESH
      02opida 02opida 14 minutes ago
      EXAI
      EXAI
      02opida 02opida 14 minutes ago
      EFRMF
      02opida 02opida 14 minutes ago
      EAPH
      EAPH
      02opida 02opida 14 minutes ago
      CLM
      02opida 02opida 14 minutes ago
      EKG
      02opida 02opida 14 minutes ago
      CYIO
      CYIO
      02opida 02opida 15 minutes ago
      EMBR
      EMBR
      02opida 02opida 15 minutes ago
      NGCG
      NGCG
      02opida 02opida 15 minutes ago
      BRGO
      BRGO
      02opida 02opida 16 minutes ago
      ONCS
      02opida 02opida 16 minutes ago
      ECSL
      ECSL
      02opida 02opida 17 minutes ago
      morning mick & BDEZ & glenn19
      02opida 02opida 17 minutes ago
      CJET........................https://stockcharts.com/h-sc/ui?s=CJET&p=W&b=5&g=0&id=p28463073231
      CJET
      02opida 02opida 18 minutes ago
      all most 60 this am
      02opida 02opida 18 minutes ago
      HI THERE 02 & ALL, 4th Stimulus Check of $1,400 Expected Dates, For Social Security, SSDI, SSI & COLA 2024 Money News

      Your Recent History

      LSE
      PVN
      Proven Vct
      AMEX
      BRIL
      Delayed Upgrade Clock